Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Progressive Pulmonary Fibrosis Market Size in the 7MM was USD 1,300 Million in 2023, estimated DelveInsight
Banco Santander S.A. Grows Position in Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Trading Up 1.6% – Should You Buy?
338,118 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by Integrated Investment Consultants LLC
Cypress Capital Group Lowers Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Charles Schwab Investment Management Inc.
Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by Banco Santander S.A.
Investors Research Corp Acquires 607 Shares of Bristol-Myers Squibb (NYSE:BMY)
Trustmark National Bank Trust Department Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Intech Investment Management LLC
Non-small Cell Lung Cancer Treatment Market 2032: Clinical Trials, Medication, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight
Commerce Bank Sells 30,241 Shares of Bristol-Myers Squibb (NYSE:BMY)
77,494 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by B. Metzler seel. Sohn & Co. Holding AG
Prospera Financial Services Inc Grows Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Holdings Trimmed by Moors & Cabot Inc.
First Horizon Advisors Inc. Raises Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Pzena Investment Management LLC Increases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Portfolio Design Labs LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)
Ontario Teachers Pension Plan Board Sells 86,115 Shares of Bristol-Myers Squibb (NYSE:BMY)
First Horizon Advisors Inc. Acquires 291,613 Shares of Bristol-Myers Squibb (NYSE:BMY)
Advisors Asset Management Inc. Increases Stake in Bristol-Myers Squibb (NYSE:BMY)
Jennison Associates LLC Increases Position in Bristol-Myers Squibb (NYSE:BMY)
West Family Investments Inc. Takes $296,000 Position in Bristol-Myers Squibb (NYSE:BMY)
Premier Fund Managers Ltd Takes Position in Bristol-Myers Squibb (NYSE:BMY)
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It - November 20, 2024 - Zacks.com
'Mag 7' leads reversal — plus, we're adding a new stock to our Bullpen watchlist
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by PNC Financial Services Group Inc.
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by First City Capital Management Inc.
Meeder Asset Management Inc. Boosts Holdings in Bristol-Myers Squibb (NYSE:BMY)
OneAscent Financial Services LLC Purchases Shares of 8,855 Bristol-Myers Squibb (NYSE:BMY)
Aviance Capital Partners LLC Lowers Position in Bristol-Myers Squibb (NYSE:BMY)
MAI Capital Management Sells 26,254 Shares of Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Natixis Advisors LLC
Zacks Research Has Strong Forecast for BMY FY2024 Earnings
Bristol-Myers Squibb (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.1% - Time to Sell?
Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
Mill Creek Capital Advisors LLC Sells 9,989 Shares of Bristol-Myers Squibb (NYSE:BMY)
Expanded Ultrasound Use in RA, New Technology Spur Updated Guidance | MDedge
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and MiMedx Group (MDXG)
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Swiss National Bank
Alpha Family Trust Purchases 9,430 Shares of Bristol-Myers Squibb (NYSE:BMY)
Seizert Capital Partners LLC Purchases 109,849 Shares of Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Daiwa America
Mizuho Markets Americas LLC Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY)
Kentucky Retirement Systems Has $7.31 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Raised to “Outperform” at Leerink Partners
Morgan Stanley Increases Bristol-Myers Squibb (NYSE:BMY) Price Target to $39.00
Bristol-Myers Squibb (NYSE:BMY) Trading Down 3% - Here's Why
Morgan Stanley Issues Positive Forecast for Bristol-Myers Squibb (NYSE:BMY) Stock Price
Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by Sheaff Brock Investment Advisors LLC
Bristol-Myers Squibb (NYSE:BMY) Now Covered by Analysts at Wolfe Research
Bristol Myers Gets CHMP Backing for Augtyro Cancer Drug | Morningstar
EMA committee recommends repotrectinib for lung cancer By Investing.com
Bristol-Myers Squibb (NYSE:BMY) Upgraded to "Strong-Buy" at Daiwa America
What is William Blair’s Forecast for BMY FY2025 Earnings?
William Blair Has Negative Forecast for BMY Q4 Earnings
Bristol-Myers Squibb (NYSE:BMY) Shares Down 0.2% - Here's Why
Bristol-Myers Squibb (NYSE:BMY) Shares Down 0.2% – What’s Next?
Kovack Advisors Inc. Cuts Stock Position in Bristol-Myers Squibb (NYSE:BMY)
Sargent Investment Group LLC Buys Shares of 9,269 Bristol-Myers Squibb (NYSE:BMY)
ING Groep NV Boosts Holdings in Bristol-Myers Squibb (NYSE:BMY)
Lifeworks Advisors LLC Increases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Zions Bancorporation N.A. Purchases 23,001 Shares of Bristol-Myers Squibb (NYSE:BMY)
Plato Investment Management Ltd Purchases 13,447 Shares of Bristol-Myers Squibb (NYSE:BMY)
Oligometastatic Disease Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Therapies, Companies by DelveInsight
Venturi Wealth Management LLC Grows Stake in Bristol-Myers Squibb (NYSE:BMY)
Citigroup Increases Bristol-Myers Squibb (NYSE:BMY) Price Target to $60.00
Bristol-Myers Squibb (NYSE:BMY) Shares Up 12.4% – Time to Buy?
Bristol-Myers Squibb (NYSE:BMY) Shares Down 0.6% - What's Next?
Is Bristol-Myers Squibb Company (BMY) Among The Top Dividend Contenders Right Now?
Mengis Capital Management Inc. Trims Stock Position in Bristol-Myers Squibb (NYSE:BMY)
Oppenheimer Asset Management Inc. Increases Position in Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Oppenheimer & Co. Inc.
Bristol-Myers Squibb (NYSE:BMY) Raised to "Outperform" at Daiwa Capital Markets
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Saturna Capital Corp
Pinnacle Financial Partners Inc Raises Holdings in Bristol-Myers Squibb (NYSE:BMY)
Mengis Capital Management Inc. Sells 9,535 Shares of Bristol-Myers Squibb (NYSE:BMY)
Aigen Investment Management LP Sells 102,823 Shares of Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) Upgraded by Leerink Partnrs to Strong-Buy Rating
Bristol-Myers Squibb (NYSE:BMY) Price Target Raised to $60.00 at Citigroup
BMO Capital Markets Boosts Bristol-Myers Squibb (NYSE:BMY) Price Target to $61.00
American Assets Inc. Purchases New Holdings in Bristol-Myers Squibb (NYSE:BMY)
Jaffetilchin Investment Partners LLC Buys 393 Shares of Bristol-Myers Squibb (NYSE:BMY)
Morgan Stanley Raises Bristol-Myers Squibb (NYSE:BMY) Price Target to $39.00
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Commonwealth Retirement Investments LLC
Bristol-Myers Squibb (NYSE:BMY) Upgraded at Leerink Partners
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Entropy Technologies LP
Atria Investments Inc Has $6.62 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial
AbbVie Stock Declines as Schizophrenia Studies Fail, BMY Gains - November 12, 2024 - Zacks.com
3 Stocks Seeing Insider Buys: CNC, PFE, BMY - November 12, 2024 - Zacks.com
Bristol-Myers Squibb (NYSE:BMY) Shares Up 12.4% - Here's What Happened
Trending: Bristol-Myers Squibb Shares Up on Setback for AbbVie Schizophrenia Drug | Morningstar
Bristol-Myers Squibb (NYSE:BMY) Shares Gap Up - What's Next?
Bristol-Myers Squibb Target of Unusually High Options Trading (NYSE:BMY)
Bristol-Myers Squibb Up Over 11%, on Pace for Largest Percent Increase Since March 2000 — Data Talk | Morningstar
Crossmark Global Holdings Inc. Sells 160,079 Shares of Bristol-Myers Squibb (NYSE:BMY)
Latest news
MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K
Nasdaq futures decline, Nvidia shares dip following the earnings report
Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024